Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
The Journal of Clinical Endocrinology & Metabolism, 2022, Vol. 107, No. 1, 1–9
Consensus Statement
The Journal of Clinical Endocrinology & Metabolism, 2022, Vol. 107, No. 1, 1–9
Consensus Statement
Endocrinología, Diabetes y Nutrición
Online 21 octubre 2022
Texto completo: https://www.seen.es/portal/documentos/texto-completo-abordaje-integral-dm2-2022
Proporcionar recomendaciones prácticas para el abordaje integral de las personas con diabetes tipo 2 según la medicina basada en la evidencia.
Miembros del Área de Conocimiento de Diabetes de la Sociedad Española de Endocrinología y Nutrición.
Kidney internacional
VOLUME 102 | ISSUE 5S | NOVEMBER 2022
The objective of this clinical practice guideline is to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, diabetes-care teams, other health care professionals and stakeholders, and individuals with diabetes and their caregivers.
CONSENSUS REPORT| SEPTEMBER 23 2022
Diabetes care
Enlace artículo:
10.2337/dci22-0034/147671/Management-of-Hyperglycemia-in-Type-2-Diabetes
Diapositivas:
JAMA Clinical Guidelines Synopsis
July 11, 2022
Major recommendations
Diet, physical activity, and behavioral therapy should be designed to achieve and maintain at least 5% weight loss. Additional weight loss usually results in further improvements in control of diabetes and cardiovascular risk (level of evidence B).
Interventions to achieve weight loss should include a high frequency of counseling (≥16 sessions in 6 months) to achieve a 500- to 750-kcal/d energy deficit (level of evidence A).